InMode (INMD) Liabilities and Shareholders Equity (2018 - 2026)

InMode (INMD) posted quarterly Liabilities and Shareholders Equity of $750.8 million for Q1 2026, up 6.54% year-on-year from $704.7 million in Q1 2025, and down 2.03% on a QoQ basis from $766.4 million in Q4 2025.

InMode (INMD) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $750.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 6.54% year-over-year to $750.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 6.74% YoY) and the FY2025 annual result came in at $766.4 million, down 2.45% from the prior year.
  • Liabilities and Shareholders Equity retreated to $750.8 million in Q1 2026 per INMD's latest filing, from $766.4 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for INMD reached as high as $891.7 million in Q1 2024 and fell as low as $464.5 million in Q1 2022.
  • A 5-year average of $723.4 million and a median of $734.6 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity surged 44.17% — and 2025, when it decreased 20.97%.
  • Year by year, Liabilities and Shareholders Equity stood at $644.4 million in 2022, then soared by 33.97% to $863.3 million in 2023, then slipped by 8.99% to $785.7 million in 2024, then dropped by 2.45% to $766.4 million in 2025, then declined by 2.03% to $750.8 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $750.8 million, $766.4 million, and $734.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 InMode 956,721.10 -479.17 Mn 61.55 Mn 750.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 750.84 Mn
Dec 31, 2025 766.43 Mn
Sep 30, 2025 734.61 Mn
Jun 30, 2025 708.35 Mn
Mar 31, 2025 704.74 Mn
Dec 31, 2024 785.67 Mn
Sep 30, 2024 824.03 Mn
Jun 30, 2024 859.84 Mn
Mar 31, 2024 891.74 Mn
Dec 31, 2023 863.29 Mn
Sep 30, 2023 793.53 Mn
Jun 30, 2023 734.08 Mn
Mar 31, 2023 669.61 Mn
Dec 31, 2022 644.41 Mn
Sep 30, 2022 578.98 Mn
Jun 30, 2022 523.21 Mn
Mar 31, 2022 464.47 Mn
Dec 31, 2021 478.54 Mn
Sep 30, 2021 447.66 Mn
Jun 30, 2021 383.03 Mn